Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Stephan, C; Jung, K (2010). MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urologic Oncology, 28(1):4-13.

Meyer, H A; Tölle, A; Jung, M; Fritzsche, F R; Haendler, B; Kristiansen, I; Gaspert, A; Johannsen, M; Jung, K; Kristiansen, G (2009). Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. European Urology, 55(3):669-678.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Erbersdobler, A; Stephan, C; Jung, K (2009). Mikro-RNA in der Uroonkologie. Neue Hoffnungen für die Diagnostik und Therapie von Tumoren? Der Urologe. Ausg. A, 48(8):877-885.

Fritzsche, F R; Jung, M; Tölle, A; Wild, P; Hartmann, A; Wassermann, K; Rabien, A; Lein, M; Dietel, M; Pilarsky, C; Calvano, D; Grützmann, R; Jung, K; Kristiansen, G (2008). ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. European Urology, 54(5):1097-1108.

Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.

Volk, M; Jung, M; Richarz, D (1995). GTU - A workbench for the development of natural language grammars. In: Conference on Practical Applications of Prolog, Paris, France, 1995 - 1995.

Jung, M; Richarz, D; Volk, M (1994). GTU - Eine Grammatik-Testumgebung. In: KONVENS-94, Vienna, Austria, 28 September 1994 - 30 September 1994, 427-430.

This list was generated on Sat Oct 21 16:22:36 2017 CEST.